Just like when your favorite ice cream shop has to cut back on its supply because everyone wants a taste, Novo Nordisk, the Danish drug developer, is having to halve the supply of starter doses for their popular Wegovy weight-loss drug. The high demand for Wegovy follows the company’s impressive results, which exceeded expectations. However, this means that there may be a shorter supply available to those looking to start their weight-loss journey with the drug. But don’t worry, as Novo Nordisk is likely working hard to meet the increased demand and ensure that everyone can eventually get their hands on Wegovy. This news highlights the success of the drug and its effectiveness in helping individuals lose weight. To find out more about the study behind this powerful weight-loss drug, check out the underlying research below!
